These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

859 related articles for article (PubMed ID: 28741521)

  • 1. Hypoxia-Inducible Factors: Master Regulators of Cancer Progression.
    Schito L; Semenza GL
    Trends Cancer; 2016 Dec; 2(12):758-770. PubMed ID: 28741521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-inducible factors: cancer progression and clinical translation.
    Wicks EE; Semenza GL
    J Clin Invest; 2022 Jun; 132(11):. PubMed ID: 35642641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor and its microenvironment: a synergistic interplay.
    Catalano V; Turdo A; Di Franco S; Dieli F; Todaro M; Stassi G
    Semin Cancer Biol; 2013 Dec; 23(6 Pt B):522-32. PubMed ID: 24012661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
    Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
    Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIFs, angiogenesis, and cancer.
    Yang Y; Sun M; Wang L; Jiao B
    J Cell Biochem; 2013 May; 114(5):967-74. PubMed ID: 23225225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia inducible factors in cancer stem cells.
    Heddleston JM; Li Z; Lathia JD; Bao S; Hjelmeland AB; Rich JN
    Br J Cancer; 2010 Mar; 102(5):789-95. PubMed ID: 20104230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy.
    Semenza GL
    Trends Pharmacol Sci; 2012 Apr; 33(4):207-14. PubMed ID: 22398146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-inducible factors in cancer stem cells and inflammation.
    Peng G; Liu Y
    Trends Pharmacol Sci; 2015 Jun; 36(6):374-83. PubMed ID: 25857287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Stabilization and Activity of the HIFs Important for Hypoxia-Induced Signalling in Cancer Cells.
    Chiu DK; Zhang MS; Tse AP; Wong CC
    Methods Mol Biol; 2019; 1928():77-99. PubMed ID: 30725452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-inducible factors as key regulators of tumor inflammation.
    Mamlouk S; Wielockx B
    Int J Cancer; 2013 Jun; 132(12):2721-9. PubMed ID: 23055435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-inducible factor 1 and breast cancer metastasis.
    Liu ZJ; Semenza GL; Zhang HF
    J Zhejiang Univ Sci B; 2015 Jan; 16(1):32-43. PubMed ID: 25559953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of hypoxia inducible factor-1 in cancer stem cells (Review).
    Zhang Q; Han Z; Zhu Y; Chen J; Li W
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of hypoxia in the hallmarks of human cancer.
    Ruan K; Song G; Ouyang G
    J Cell Biochem; 2009 Aug; 107(6):1053-62. PubMed ID: 19479945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer.
    Wigerup C; Påhlman S; Bexell D
    Pharmacol Ther; 2016 Aug; 164():152-69. PubMed ID: 27139518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia and hypoxia-inducible factors: master regulators of metastasis.
    Lu X; Kang Y
    Clin Cancer Res; 2010 Dec; 16(24):5928-35. PubMed ID: 20962028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging roles of hypoxia-inducible factors and reactive oxygen species in cancer and pluripotent stem cells.
    Saito S; Lin YC; Tsai MH; Lin CS; Murayama Y; Sato R; Yokoyama KK
    Kaohsiung J Med Sci; 2015 Jun; 31(6):279-86. PubMed ID: 26043406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-Driven Effects in Cancer: Characterization, Mechanisms, and Therapeutic Implications.
    Shi R; Liao C; Zhang Q
    Cells; 2021 Mar; 10(3):. PubMed ID: 33808542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIF expression and the role of hypoxic microenvironments within primary tumours as protective sites driving cancer stem cell renewal and metastatic progression.
    Philip B; Ito K; Moreno-Sánchez R; Ralph SJ
    Carcinogenesis; 2013 Aug; 34(8):1699-707. PubMed ID: 23740838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors.
    Xia Y; Choi HK; Lee K
    Eur J Med Chem; 2012 Mar; 49():24-40. PubMed ID: 22305612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The crosstalk between HIFs and mitochondrial dysfunctions in cancer development.
    Bao X; Zhang J; Huang G; Yan J; Xu C; Dou Z; Sun C; Zhang H
    Cell Death Dis; 2021 Feb; 12(2):215. PubMed ID: 33637686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.